Review of depot aripiprazole for schizophrenia

Review of depot aripiprazole for schizophrenia

Farha Bilal Motiwala, Kim Stasia Siscoe, Rif S El-Mallakh Mood Disorders Research Program, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY, USA Abstract: Improving outcomes in schizophrenia generally requires an improvement in medication...

Full description

Bibliographic Details
Main Authors:	Motiwala FB, Siscoe KS, El-Mallakh RS
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-11-01
Series:	Patient Preference and Adherence
Online Access:	http://www.dovepress.com/review-of-depot-aripiprazole-for-schizophrenia-a14976

Similar Items

Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection
by: Wang SM, et al.
Published: (2014-08-01)

Síndrome neuroléptico maligno por aripiprazol depot
by: A. Contreras Chicote, et al.
Published: (2023-06-01)

Transdermal Asenapine in Schizophrenia: A Systematic Review
by: Carrithers B, et al.
Published: (2020-08-01)

Aripiprazole in schizophrenia: consensus guidelines.
by: Travis, M, et al.
Published: (2005)

Schizophrenia: effects of aripiprazole in metabolic syndrome
by: Deborah Galvão Coelho da Silva, et al.
Published: (2019-11-01)

Clinical experience with the new double aripiprazole depot regime in a psychiatric hospitalization unit
by: Á. Moleón Ruiz, et al.
Published: (2022-06-01)

Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia
by: Kidambi N, et al.
Published: (2023-05-01)

Aripiprazole-associated tic in a schizophrenia patient
by: Guo X, et al.
Published: (2015-03-01)

Effect of aripiprazole on mismatch negativity (MMN) in schizophrenia.
by: Zhenhe Zhou, et al.
Published: (2013-01-01)

Differences in autonomic nervous system activity between long-acting injectable aripiprazole and oral aripiprazole in schizophrenia
by: Saki Hattori, et al.
Published: (2023-03-01)

The use of aripiprazole in early onset schizophrenia: safety and efficacy
by: Ibrahim, Normala, et al.
Published: (2009)

Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan
by: Yun Tien, et al.
Published: (2022-07-01)

Treatment of refractory catatonic schizophrenia with low dose aripiprazole
by: Sasaki Tsuyoshi, et al.
Published: (2012-05-01)

Aripiprazole for refractory catatonic schizophrenia – A case report
by: Saisudha N V Gorthi, et al.
Published: (2015-01-01)

Hospitalization rates and resource utilization of schizophrenic patients switched from oral antipsychotics to aripiprazole-depot in Germany
by: Christoph Potempa, et al.
Published: (2018-11-01)

Cognitive Impairment in Schizophrenia, Neurotransmitters and the New Atypical Antipsychotic Aripiprazole
by: Topolov Mariyan K., et al.
Published: (2016-03-01)

The role of aripiprazole in improvement of penile erection in schizophrenia patients with erectile dysfunction
by: Debby Handayati Harahap, et al.
Published: (2021-08-01)

Participant Engagement and Symptom Improvement: Aripiprazole Tablets with Sensor for the Treatment of Schizophrenia
by: Cochran JM, et al.
Published: (2022-07-01)

Cost/effectiveness of aripiprazole vs. olanzapine in the long-term treatment of schizophrenia
by: Dutina Aleksandra, et al.
Published: (2019-01-01)

Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study
by: Daniel Schöttle, et al.
Published: (2018-11-01)

The effect of switching from oral low-dose aripiprazole to aripiprazole once-monthly 300 mg on the quality of life in three patients with schizophrenia
by: Hidenobu Suzuki, et al.
Published: (2017-05-01)

Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study
by: Daniel Schöttle, et al.
Published: (2018-12-01)

Effects of Aripiprazole on Olanzapine Population Pharmacokinetics and Initial Dosage Optimization in Schizophrenia Patients
by: Zhang C, et al.
Published: (2024-03-01)

Aripiprazole lai two-injection start in a 16 year-old with Schizophrenia
by: B. Marpepa, et al.
Published: (2022-06-01)

Aripiprazole in the treatment of acute episode of schizophrenia: a real-world study in China
by: Qian Li, et al.
Published: (2023-05-01)

Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis
by: Gloria Giordano, et al.
Published: (2020-01-01)

Aripiprazole treatment effects on metabolic syndrome parameters in schizophrenia patients: Preliminary results
by: Said, M.A., et al.
Published: (2010)

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
by: Kishi T, et al.
Published: (2015-02-01)

Strategies to improve medication adherence in patients with schizophrenia: the role of support services
by: El-Mallakh P, et al.
Published: (2015-04-01)

Combined Aripiprazole and Electroconvulsive Therapy in a Patient with Treatment-Resistant Schizophrenia and QT Prolongation
by: Nordin, Muhammad Farhan, et al.
Published: (2018)

Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels
by: Minami Tasaki, et al.
Published: (2021-09-01)

Augmentation of aripiprazole by flupenthixol decanoate in poorly responsive schizophrenia: a randomized clinical study
by: Saeed Shoja Shafti
Published: (2017-07-01)

Aripiprazole LAI two‐injection start in a 16 year‐old adolescent with schizophrenia
by: Virginio Salvi, et al.
Published: (2022-06-01)

Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia
by: Joseph P. McEvoy, et al.
Published: (2021-03-01)

Dynamics of mental state and prolactin levels in patients with chronic schizophrenia during aripiprazole therapy
by: L. N. Gorobets, et al.
Published: (2023-07-01)

Aripiprazol e síndrome de Tourette Aripiprazole and Tourette syndrome
by: Ana Hounie, et al.
Published: (2004-09-01)

Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review
by: Kunal Maini, et al.
Published: (2021-07-01)

Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
by: Oya K, et al.
Published: (2015-09-01)

Chlorine Atoms of an Aripiprazole Molecule Control the Geometry and Motion of Aripiprazole and Deschloro-aripiprazole in Subdomain IIIA of Human Serum Albumin
by: Akito Kawai, et al.
Published: (2022-08-01)

Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study
by: Pierre-Michel Llorca, et al.
Published: (2022-05-01)